BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang K, Lu Y, Harley KT, Tran MH. Atypical Hemolytic Uremic Syndrome: A Brief Review. Hematol Rep 2017;9:7053. [PMID: 28626544 DOI: 10.4081/hr.2017.7053] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Espeter F, Brenner T. [Thrombocytopenia, anemia and acute kidney injury in operative intensive care medicine : What are your first thoughts?]. Anaesthesiologie 2023;72:1-2. [PMID: 36656316 DOI: 10.1007/s00101-022-01233-5] [Reference Citation Analysis]
2 Serrano M, Espinosa G, Serrano A, Cervera R. COVID-19 and the antiphospholipid syndrome. Autoimmun Rev 2022;21:103206. [PMID: 36195247 DOI: 10.1016/j.autrev.2022.103206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Halimi JM, Al-Dakkak I, Anokhina K, Ardissino G, Licht C, Lim WH, Massart A, Schaefer F, Walle JV, Rondeau E. Clinical characteristics and outcomes of a patient population with atypical hemolytic uremic syndrome and malignant hypertension: analysis from the Global aHUS registry. J Nephrol 2022. [PMID: 36152218 DOI: 10.1007/s40620-022-01465-z] [Reference Citation Analysis]
4 Smarz-Widelska I, Syroka-Główka M, Janowska-Jaremek J, Kozioł MM, Załuska W. Atypical Hemolytic Uremic Syndrome after SARS-CoV-2 Infection: Report of Two Cases. Int J Environ Res Public Health 2022;19. [PMID: 36141710 DOI: 10.3390/ijerph191811437] [Reference Citation Analysis]
5 Tanaka C, Naito Y, Suehiro S, Sano C, Ohta R. Device-Related Thrombotic Microangiopathy in an Elderly Patient With a History of Aortic Surgery. Cureus 2022. [DOI: 10.7759/cureus.27937] [Reference Citation Analysis]
6 Conway EM, Pryzdial ELG. Complement contributions to COVID-19. Curr Opin Hematol 2022. [PMID: 35852851 DOI: 10.1097/MOH.0000000000000724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tran M, Penalosa P, Hamiduzzaman A, Hanna R. Pregnancy associated atypical hemolytic uremic syndrome triggered by massive uterine bleeding after outpatient dilatation and evacuation. Journal of Onco-Nephrology 2022;6:59-63. [DOI: 10.1177/23993693211058192] [Reference Citation Analysis]
8 Alhamoud I, Freiberg SA. Successful Discontinuation of Eculizumab in a Pediatric Patient With Atypical Hemolytic Uremic Syndrome and Underlying Systematic Lupus Erythematosus. Cureus 2022. [DOI: 10.7759/cureus.25117] [Reference Citation Analysis]
9 Ghazanfar H, Nawaz I, Allena N, Ashraf S, Saad M, Ali N. A Case of Atypical Hemolytic Uremic Syndrome in a Pregnant Patient. Cureus 2022. [DOI: 10.7759/cureus.25096] [Reference Citation Analysis]
10 Venier LM, Patriquin CJ, Warkentin TE. Acute thrombocytopenia suggesting thrombotic microangiopathy. Am J Hematol 2022;97:659-65. [PMID: 35253925 DOI: 10.1002/ajh.26515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Serrano M, Espinosa G, Serrano A, Cervera R. Antigens and Antibodies of the Antiphospholipid Syndrome as New Allies in the Pathogenesis of COVID-19 Coagulopathy. Int J Mol Sci 2022;23:4946. [PMID: 35563337 DOI: 10.3390/ijms23094946] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Gupta P, Gupta RK. Hemolytic Uremic Syndrome (HUS). Pathology of Glomerular Diseases 2022. [DOI: 10.1007/978-981-19-1430-0_15] [Reference Citation Analysis]
13 Plášek J, Gumulec J, Máca J, Škarda J, Procházka V, Grézl T, Václavík J. COVID-19 Associated Coagulopathy: Mechanisms and Host-Directed Treatment. Am J Med Sci 2021:S0002-9629(21)00403-1. [PMID: 34752741 DOI: 10.1016/j.amjms.2021.10.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Vissing A, Wautlet A, Jain S. An Atypical Case of Thrombotic Microangiopathy Secondary to Acute Pancreatitis. J Pediatr Hematol Oncol 2021;43:e736-8. [PMID: 33065709 DOI: 10.1097/MPH.0000000000001973] [Reference Citation Analysis]
15 Santiesteban-Lores LE, Amamura TA, da Silva TF, Midon LM, Carneiro MC, Isaac L, Bavia L. A double edged-sword - The Complement System during SARS-CoV-2 infection. Life Sci 2021;272:119245. [PMID: 33609539 DOI: 10.1016/j.lfs.2021.119245] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
16 Ávila A, Gavela E, Sancho A. Thrombotic Microangiopathy After Kidney Transplantation: An Underdiagnosed and Potentially Reversible Entity. Front Med (Lausanne) 2021;8:642864. [PMID: 33898482 DOI: 10.3389/fmed.2021.642864] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Karim S, Islam A, Rafiq S, Laher I. The COVID-19 Pandemic: Disproportionate Thrombotic Tendency and Management Recommendations. Trop Med Infect Dis 2021;6:26. [PMID: 33670475 DOI: 10.3390/tropicalmed6010026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
18 Zarantonello A, Pedersen H, Laursen NS, Andersen GR. Nanobodies Provide Insight into the Molecular Mechanisms of the Complement Cascade and Offer New Therapeutic Strategies. Biomolecules 2021;11:298. [PMID: 33671302 DOI: 10.3390/biom11020298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Cabezas-Falcon S, Norbury AJ, Hulme-Jones J, Klebe S, Adamson P, Rudd PA, Mahalingam S, Ong LC, Alonso S, Gordon DL, Carr JM. Changes in complement alternative pathway components, factor B and factor H during dengue virus infection in the AG129 mouse. J Gen Virol 2021;102. [PMID: 33410734 DOI: 10.1099/jgv.0.001547] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Conway EM, Pryzdial ELG. Is the COVID-19 thrombotic catastrophe complement-connected? J Thromb Haemost 2020;18:2812-22. [PMID: 32762081 DOI: 10.1111/jth.15050] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 14.0] [Reference Citation Analysis]
21 Lavrishcheva YV, Yakovenko AA, Kudlai DA. [The experience of using the Russian biosimilar of the original drug eculizumab for the treatment of patients with atypical hemolytic-uremic syndrome]. Ter Arkh 2020;92:76-80. [PMID: 33346497 DOI: 10.26442/00403660.2020.06.000649] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Fletcher-Sandersjöö A, Bellander BM. Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review. Thromb Res 2020;194:36-41. [PMID: 32569879 DOI: 10.1016/j.thromres.2020.06.027] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 27.0] [Reference Citation Analysis]
23 Franzin R, Stasi A, Fiorentino M, Stallone G, Cantaluppi V, Gesualdo L, Castellano G. Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage. Front Immunol 2020;11:734. [PMID: 32457738 DOI: 10.3389/fimmu.2020.00734] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 12.7] [Reference Citation Analysis]
24 Yan K, Desai K, Gullapalli L, Druyts E, Balijepalli C. Epidemiology of Atypical Hemolytic Uremic Syndrome: A Systematic Literature Review. Clin Epidemiol. 2020;12:295-305. [PMID: 32210633 DOI: 10.2147/clep.s245642] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
25 Fletcher-Sandersjöö A, Maegele M, Bellander BM. Does Complement-Mediated Hemostatic Disturbance Occur in Traumatic Brain Injury? A Literature Review and Observational Study Protocol. Int J Mol Sci 2020;21:E1596. [PMID: 32111078 DOI: 10.3390/ijms21051596] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
26 Brodszki N, Frazer-Abel A, Grumach AS, Kirschfink M, Litzman J, Perez E, Seppänen MRJ, Sullivan KE, Jolles S. European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management. J Clin Immunol 2020;40:576-91. [PMID: 32064578 DOI: 10.1007/s10875-020-00754-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 10.3] [Reference Citation Analysis]
27 Fayek SA, Allam SR, Martinez E, Pan G, Dao A, Rofaiel G. Atypical Hemolytic Uremic Syndrome After Kidney Transplantation: Lessons Learned From the Good, the Bad, and the Ugly. A Case Series With Literature Review. Transplant Proc 2020;52:146-52. [PMID: 31924403 DOI: 10.1016/j.transproceed.2019.10.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Polito MS, Machetta F, Fea AM, Eandi CM. Hypertensive choroidopathy in atypical hemolytic-uremic syndrome. Eur J Ophthalmol 2021;31:NP63-6. [PMID: 31875682 DOI: 10.1177/1120672119896286] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
29 Gulati A, Dahl N. In Reply to ‘TREX1 Mutation Causing Autosomal Dominant Thrombotic Microangiopathy and CKD Is in Fact a Case of RVCL-S Presenting With Renal Features’. American Journal of Kidney Diseases 2019;73:893-4. [DOI: 10.1053/j.ajkd.2019.01.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Cody EM, Dixon BP. Hemolytic Uremic Syndrome. Pediatr Clin North Am 2019;66:235-46. [PMID: 30454746 DOI: 10.1016/j.pcl.2018.09.011] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 14.0] [Reference Citation Analysis]
31 Kulasekararaj AG, Hill A, Rottinghaus ST, Langemeijer S, Wells R, Gonzalez-Fernandez FA, Gaya A, Lee JW, Gutierrez EO, Piatek CI, Szer J, Risitano A, Nakao S, Bachman E, Shafner L, Damokosh AI, Ortiz S, Röth A, Peffault de Latour R. Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study. Blood 2019;133:540-9. [PMID: 30510079 DOI: 10.1182/blood-2018-09-876805] [Cited by in Crossref: 159] [Cited by in F6Publishing: 166] [Article Influence: 31.8] [Reference Citation Analysis]
32 Chang JC. TTP-like syndrome: novel concept and molecular pathogenesis of endotheliopathy-associated vascular microthrombotic disease. Thromb J 2018;16:20. [PMID: 30127669 DOI: 10.1186/s12959-018-0174-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
33 Frazer-Abel A. The effect on the immunology laboratory of the expansion in complement therapeutics. J Immunol Methods 2018;461:30-6. [PMID: 30092178 DOI: 10.1016/j.jim.2018.08.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
34 Cabezas S, Bracho G, Aloia AL, Adamson PJ, Bonder CS, Smith JR, Gordon DL, Carr JM. Dengue Virus Induces Increased Activity of the Complement Alternative Pathway in Infected Cells. J Virol 2018;92:e00633-18. [PMID: 29743365 DOI: 10.1128/JVI.00633-18] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
35 Gulati A, Bale AE, Dykas DJ, Bia MJ, Danovitch GM, Moeckel GW, Somlo S, Dahl NK. TREX1 Mutation Causing Autosomal Dominant Thrombotic Microangiopathy and CKD-A Novel Presentation. Am J Kidney Dis 2018;72:895-9. [PMID: 29941221 DOI: 10.1053/j.ajkd.2018.05.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
36 Clancy M, McGhan R, Gitomer J, Inocencio AM, Aldrich C, Iaderosa R, Stevens R. Disseminated cryptococcosis associated with administration of eculizumab. Am J Health Syst Pharm 2018;75:1018-22. [PMID: 29895518 DOI: 10.2146/ajhp170708] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
37 Keragala CB, Draxler DF, McQuilten ZK, Medcalf RL. Haemostasis and innate immunity - a complementary relationship: A review of the intricate relationship between coagulation and complement pathways. Br J Haematol 2018;180:782-98. [PMID: 29265338 DOI: 10.1111/bjh.15062] [Cited by in Crossref: 79] [Cited by in F6Publishing: 87] [Article Influence: 13.2] [Reference Citation Analysis]
38 Yang N, Qiao J, Liu S, Zou Z, Zhu L, Liu X, Zhou S, Li H. Change in the immune function of porcine iliac artery endothelial cells infected with porcine circovirus type 2 and its inhibition on monocyte derived dendritic cells maturation. PLoS One 2017;12:e0186775. [PMID: 29073194 DOI: 10.1371/journal.pone.0186775] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]